Detrothyronine

Detrothyronine

SCHEMBL41654

N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)[O-].[Na+]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

THRATHRB

The experimentally established mechanism targets of Detrothyronine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB known ✓ P10828 13/20 1.00
THRA known ✓ P10827 9/20 0.78
MEN1 O00255 6/20 1.00
KMT2A Q03164 6/20 1.00
LMNA P02545 6/20 1.00
USP2 O75604 4/20 1.00
HSD17B10 Q99714 4/20 1.00
POLB P06746 3/20 1.00
HIF1A Q16665 3/20 1.00
HPGD P15428 2/20 1.00
SMN1; SMN2 Q16637 2/20 1.00
ALDH1A1 P00352 2/20 1.00
MAPT P10636 2/20 1.00
ALOX12 P18054 1/20 1.00
BLM P54132 1/20 1.00
MCL1 Q07820 1/20 1.00
L3MBTL1 Q9Y468 1/20 0.98
PCNA P12004 5/20 0.78
PPARG P37231 3/20 0.78
ABCB11 O95342 2/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Detrothyronine SCHEMBL29684887 1.00 THRB (1.00) THRBMEN1KMT2ALMNAUSP2
Detrothyronine SCHEMBL29378991 1.00 THRB (1.00) THRBMEN1KMT2ALMNAUSP2
Detrothyronine SCHEMBL41655 0.99 USP2 (1.00) THRBMEN1KMT2ALMNAUSP2
Dextrothyroxine SCHEMBL15569465 0.95 THRB (0.91) THRBMEN1KMT2ALMNAUSP2
Detrothyronine SCHEMBL1461521 0.92 THRB (0.84) THRBMEN1KMT2ALMNAUSP2
Rathyronine SCHEMBL123365 0.88 THRB (1.00) THRBMEN1KMT2ALMNAUSP2
Liothyronine SCHEMBL8300 0.88 THRB (1.00) THRBMEN1KMT2ALMNAUSP2
Detrothyronine SCHEMBL8301 0.88 THRB (1.00) THRBMEN1KMT2ALMNAUSP2
SCHEMBL16124483 0.88 THRB (0.81) THRBMEN1KMT2ALMNAUSP2
SCHEMBL4439596 0.88 THRB (0.78) THRBMEN1KMT2ALMNAUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3212 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4704805-A2 ORAL SOLUTION COMPRISING LIOTHYRONINE SODIUM LABOMED PHARMACEUTICAL COMPANY S.A. (GR) 2026-03-11 EP claimed
EP-4630022-A1 USE OF CONDITIONED MEDIUM OF CORD LINING MESENCHYMAL STEM CELLS FOR HEALING AND/OR PREVENTING THE FORMATION AND/OR RECURRENCE OF A WOUND OR A DAMAGED SKIN AREA CellResearch Corporation Pte. Ltd. (SG) 2025-10-15 EP claimed
EP-4619012-A1 USE OF CONDITIONED MEDIUM DERIVED FROM CULTIVATION OF MESENCHYMAL STEM CELLS OF THE UMBILICAL CORD FOR INDUCING, STIMULATING AND PROMOTING HAIR GROWTH AND REGENERATION CellResearch Corporation Pte. Ltd. (SG) 2025-09-24 EP claimed
US-20250290043-A1 METHOD OF ISOLATING MESENCHYMAL STEM CELLS FROM THE AMNIOTIC MEMBRANE OF THE UMBILICAL CORD, A MESENCHYMAL STEM CELL POPULATION ISOLATED FROM THE AMNIOTIC MEMBRANE OF THE UMBILICAL CORD AND A CELL CULTURE MEDIUM FOR ISOLATING MESENCHYMAL STEM CELLS FROM THE AMNIOTIC MEMBRANE OF THE UMBILICAL CORD CELLRESEARCH CORPORATION PTE. LTD. (SG) 2025-09-18 US claimed
CN-112262211-B Method for inducing or improving wound healing property of mesenchymal stem cells 细胞研究私人有限公司 2025-05-09 CN claimed
CN-109804063-B Method for separating mesenchymal stem cells from umbilical cord amniotic membrane by adopting cell culture medium 细胞研究私人有限公司 2025-02-25 CN claimed
EP-3523421-B1 A METHOD OF ISOLATING MESENCHYMAL STEM CELLS FROM UMBILICAL CORD AMNIOTIC MEMBRANE USING A CELL CULTURE MEDIUM CELLRESEARCH CORP PTE LTD (SG) 2024-12-04 EP claimed
WO-2024227895-A2 ORAL SOLUTION COMPRISING LIOTHYRONINE SODIUM LABOMED PHARMACEUTICAL COMPANY S.A. (GR) 2024-11-07 WO claimed
CN-118755662-A Islet organoid culture reagent and culture method 博奥生物集团有限公司 2024-10-11 CN claimed
CN-118546882-A Primary retina cell separation and culture method and multi-mode signal detection method 天津大学 2024-08-27 CN claimed
US-6190696-B1 MIXING LIOTHYRONINE SODIUM, IODINE SALT MIXED WITH CARRIER, DISINTEGRANT, LUBRICANT, BINDER AND FILLER GROENEWOUD PIETER J (US) 2001-02-20 US claimed
WO-2000021504-A1 ENCAPSULATION OF SENSITIVE LIQUID COMPONENTS INTO A MATRIX TO OBTAIN DISCRETE SHELF-STABLE PARTICLES GENERAL MILLS, INC. (US) 2000-04-20 WO claimed
EP-0935523-A4 EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES GEN MILLS INC (US) 1999-12-29 EP claimed
WO-1999063969-A1 STABILIZED THYROXINE MEDICATIONS GROENEWOUD PIETER J (US) 1999-12-16 WO claimed
EP-0935523-A1 EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES GENERAL MILLS, INC. (US) 1999-08-18 EP claimed
US-5811547-A Method for inducing crystalline state transition in medicinal substance NIPPON SHINYAJU CO., LTD. (JP) 1998-09-22 US claimed
EP-0751769-A4 MEDICAL TREATMENT USING THYROID HORMONES UNIV MICHIGAN (US) 1998-05-27 EP claimed
WO-1998018610-A1 EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES LENGERICH BERNHARD H VAN (US) 1998-05-07 WO claimed
EP-0751769-A1 MEDICAL TREATMENT USING THYROID HORMONES The Regents of The University of Michigan (US) 1997-01-08 EP claimed
WO-1995000135-A1 MEDICAL TREATMENT USING THYROID HORMONES THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 1995-01-05 WO claimed